Silver Book Fact

A 2002 study found that image-guided percutaneous needle biopsies are between 3 and 7 times more cost-effective than open surgical biopsies, require a shorter procedure time, result in fewer infections, and allow earlier treatment if cancer is found.

Jelinek J, Murphey M, Welker J, Henshaw R, et al. Diagnosis of Primary Bone Tumors with Image-Guided Percutaneous Biopsy: Experience with 110 tumors. Radiology. 2002; 223: 731-7. http://radiology.rsnajnls.org/cgi/content/abstract/223/3/731

Reference

Title
Diagnosis of Primary Bone Tumors with Image-Guided Percutaneous Biopsy: Experience with 110 tumors
Publication
Radiology
Publication Date
2002
Authors
Jelinek J, Murphey M, Welker J, Henshaw R, et al.
Pages
731-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A drug for testicular cancer that cost an estimated $56 million to develop led to a sharp increase in survival rate and an annual return of $166 million in treatment…  
  • Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349…  
  • Close to one third of all drugs currently in the biopharmaceutical pipeline are for cancer, with around 5,500 potential first-in-class cancer medicines in development.  
  • Breast cancer incidence rates in women decreased 3.5% per year from 2001-2004, the first decrease observed in 20 years.  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in development is designed to induce a powerful immune response to melanoma.